Loading…
Based on limited metadata, this warning letter issued to Cross Brands Contract Filling, LLC on December 17, 2019, addresses compliance issues related to drug manufacturing or contract filling operations. The specific violations cannot be detailed as the subject line and full letter text are not available. The letter falls under FDA's drug product regulatory jurisdiction, though the specific issuing office is unknown. Without access to the complete warning letter, the exact nature of the manufacturing, quality control, or compliance deficiencies cannot be determined.